Atypical <i>BRAF</i> and <i>NRAS</i> Mutations in Mucosal Melanoma

by Nicolas Dumaz, Fanélie Jouenne, Julie Delyon, Samia Mourah, Armand Bensussan, Céleste Lebbé
Published 2019-08-01

FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma

by Pauline Tétu, Julie Delyon, Jocelyne André, Coralie Reger de Moura, Malak Sabbah, Ghanem E Ghanem, Maxime Battistella, Samia Mourah, Céleste Lebbé, Nicolas Dumaz
Published 2020-04-01

Systemic Treatment Initiation in Classical and Endemic Kaposi’s Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study

by Lina Benajiba, Jérôme Lambert, Roberta La Selva, Delphine Cochereau, Barouyr Baroudjian, Jennifer Roux, Jérôme Le Goff, Cécile Pages, Maxime Battistella, Julie Delyon, Céleste Lebbé
Published 2021-05-01

Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases

by Pauline Tétu, Lila Sirven-Villaros, Stefania Cuzzubbo, Renata Ursu, Barouyr Baroudjian, Julie Delyon, François Nataf, Constance De Margerie-Mellon, Clara Allayous, Wendy Lefevre, Antoine F. Carpentier, Céleste Lebbé
Published 2020-09-01

Baseline Genomic Features in <i>BRAFV600</i>-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care

by Baptiste Louveau, Fanelie Jouenne, Coralie Reger de Moura, Aurelie Sadoux, Barouyr Baroudjian, Julie Delyon, Florian Herms, Adele De Masson, Laetitia Da Meda, Maxime Battistella, Nicolas Dumaz, Celeste Lebbe, Samia Mourah
Published 2019-08-01

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma

by Coralie Reger de Moura, Laetitia Vercellino, Fanélie Jouenne, Barouyr Baroudjian, Aurélie Sadoux, Baptiste Louveau, Julie Delyon, Kevin Serror, Lauriane Goldwirt, Pascal Merlet, Fanny Bouquet, Maxime Battistella, Céleste Lebbé, Samia Mourah
Published 2020-02-01

Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes

by Thuy Thi Nguyen, Guillaume Gapihan, Pauline Tetu, Frédéric Pamoukdjian, Morad El Bouchtaoui, Christophe Lebœuf, Jean‐Paul Feugeas, Justine Paris, Barouyr Baroudjian, Julie Delyon, Samia Mourah, Céleste Lebbé, Anne Janin, Guilhem Bousquet, Maxime Battistella
Published 2020-12-01

Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans

by Jessica Beaziz, Maxime Battistella, Julie Delyon, Cécile Farges, Oren Marco, Cécile Pages, Christine Le Maignan, Laetitia Da Meda, Nicole Basset-Seguin, Matthieu Resche-Rigon, Anouk Walter Petrich, Delphine Kérob, Céleste Lebbé, Barouyr Baroudjian
Published 2021-05-01

Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study

by Sandra Huynh, Laurent Mortier, Caroline Dutriaux, Eve Maubec, Marie Boileau, Olivier Dereure, Marie-Therese Leccia, Jean-Philippe Arnault, Florence Brunet-Possenti, Francois Aubin, Brigitte Dreno, Marie Beylot-Barry, Celeste Lebbe, Wendy Lefevre, Julie Delyon
Published 2020-06-01